Please provide your email address to receive an email when new articles are posted on . A Canadian neuroimaging company has received an investment from the Alzheimer’s Drug Discovery Foundation to ...
Vancouver, British Columbia--(Newsfile Corp. - September 27, 2021) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a clinical stage biotech company dedicated to ...
Is AI the key to unlocking the mysteries of Alzheimer's? Neuroimaging startup Imeka is betting on it
In just the last few decades, medicine has accelerated at a mind-boggling rate, with the advent of genetic sequencing, surgical robots and other futuristic technology. Amid all this innovation, ...
SHERBROOKE, QC, Jan. 11, 2022 /PRNewswire/ -- Imeka, the leading neuroimaging company combining diffusion imaging and AI to map white matter integrity, today announced a collaboration with Atara ...
An artificial-intelligence-powered software tool that builds a detailed map of the brain's white matter to quantify the effects of Alzheimer’s disease, multiple sclerosis and other conditions has been ...
SHERBROOKE, QC, July 20, 2021 /PRNewswire/ -- Imeka, the leading neuroimaging company combining diffusion imaging and AI to map white matter integrity, today announced a partnership with INmune Bio, ...
SHERBROOKE, QC, Oct. 24, 2023 /PRNewswire/ -- Imeka, the leading neuroimaging company combining diffusion imaging and AI to map white matter microstructure, today announced an investment from the ...
Advanced Neuro Diagnostic Imaging (ANDI) software extracts features from medical images to map and analyze microstructural properties of white matter Provides adjunctive information for use with the ...
IXICO plc (AIM: IXI), the medical imaging advanced analytics company delivering intelligent insights in neuroscience, announces a collaboration agreement with IMEKA Solutions Inc. ("Imeka") to provide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results